SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032988
Filing Date
2021-06-15
Accepted
2021-06-15 16:11:43
Documents
12
Period of Report
2021-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nktx-8k_20210611.htm   iXBRL 8-K 44219
  Complete submission text file 0001564590-21-032988.txt   177322

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nktx-20210611.xsd EX-101.SCH 5760
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktx-20210611_lab.xml EX-101.LAB 20227
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktx-20210611_pre.xml EX-101.PRE 12072
5 EXTRACTED XBRL INSTANCE DOCUMENT nktx-8k_20210611_htm.xml XML 3685
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 211018667
SIC: 2834 Pharmaceutical Preparations